Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2017 / Cilt: 63 - Sayı: 2

Economic burden of stroke

Pages
155–159
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Preventive social measures are necessary to reduce this cost

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to estimate the annual economic cost per hemiplegic patient in Turkey.Patients and methods: Between September 2014 and December 2014, a total of 84 hemiplegic patients (53 males, 31 females; mean age 61.4±13.5 years; range 28-89 years) with stroke for 12 months were included in the study.
📊
Key Findings & Data:Prices of medical resources were obtained from the 2014 Healthcare Implementation Notification payment list.Results: At the end of the study, the average direct cost and indirect cost per patient were calculated respectively as 10,594.90±6,554.20 Turkish liras and 9,357.10±10,195.60 Turkish liras (4,606.47±2,849.65 USD and 4,068.30±4,432.86 USD).
💡
Conclusion & Impact:Preventive social measures are necessary to reduce this cost
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to estimate the annual economic cost per hemiplegic patient in Turkey.Patients and methods: Between September 2014 and December 2014, a total of 84 hemiplegic patients (53 males, 31 females; mean age 61.4±13.5 years; range 28-89 years) with stroke for 12 months were included in the study. Type of cerebrovascular accident and complications were evaluated. Hospital records and data from the relatives of the patients were used to calculate the cost. Annual costs were evaluated starting from first hospitalization. Direct costs were calculated with the sum of hospital care (acute care, diagnostic investigations, treatment and rehabilitation), medications, medical visits, outpatient rehabilitation and orthopedic aids. Indirect costs were calculated by taking the income loss due to absence from work into consideration. Prices of medical resources were obtained from the 2014 Healthcare Implementation Notification payment list.Results: At the end of the study, the average direct cost and indirect cost per patient were calculated respectively as 10,594.90±6,554.20 Turkish liras and 9,357.10±10,195.60 Turkish liras (4,606.47±2,849.65 USD and 4,068.30±4,432.86 USD). We found a negative correlation between total cost and age (p=0.001), and a positive correlation with duration of hospitalization (p=0.001) and number of complications (p=0.049). We were unable to find any relation of cost with sex and cerebrovascular accident type. Spasticity (p=0.028) and epilepsy (p=0.037) being among the complications were observed to increase the cost.Conclusion: Stroke is an important economic burden for Turkish population. Preventive social measures are necessary to reduce this cost

🔖

Cite This Article

YUMUŞAKHUYLU, Y., İÇAĞASIOĞLU, A., BAKLACIOĞLU, H. Ş., MURAT, S., MESCİ, N., MESCİ, E. (2022). Economic burden of stroke. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 63 - Sayı: 2, 155–159. https://ajindex.com/articles/628575

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42. 2. di Carlo A. Human and economic burden of stroke. Age and Aging 2009;38:4-5
  2. Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing 2009;38:27-32
  3. Evers SMAA, Struijts JN, Ament AJHA, Genugten MLL, Jager CJ, Boss GAM. Comments, opinions and reviews: International comparison of stroke cost studies. Stroke 2004;35:1209-15
  4. Türkiye Hastalık Yükü Çalışması 2004. In: Ünivar N, Mollahaliloğlu S, Yardım N, editors. Ankara 2006. RSHMB Hıfzısıhha Mektebi Müdürlüğü, Sağlık Bakanlığı, Aydoğdu Ofset Matbaacılık; 2007. s. 42-51
  5. Abakcı G, Abacı A, Ertaş FS, Özerkan F, Erol Ç, Oto A. Türkiye’de hipertansif hastalarda inme riski ve inme riski açısından bölgesel farklılıkların belirlenmesi: Hastane tabanlı, kesitsel, epidemiyolojik anket (THİNK) çalışması. Türk Kardiyol Dern Arş 2006;34:395-405 7. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-80
  6. Selçuk B, Kumbara F, Kurtaran A, Ersöz M, Akyüz M. Cost analysis of patients with stroke during their stay in a rehabilitation center. Fiziksel Tıp 2005;8:95-101
  7. Available from: https://www.sgk.gov.tr/wps/portal/tr/ mevzuat/yururlukteki_mevzuat/tebligler/ 10. Ommaty R. Vital ilaç rehberi. İstanbul: Pelikan Tıp ve Teknik Kitapçılık; 2014
  8. Ghatnekar O, Persson U, Glader EL, Terént A. Cost of stroke in Sweden: an incidence estimate. Int J Technol Assess Health Care 2004;20:375-80
  9. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, Emmert M, Baltzer N, Neundörfer B, et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 2006;37:1179-83
  10. Youman P, Wilson K, Harraf F, Kalra L. Youman P, Wilson K, Harraf F, Kalra L. Pharmacoeconomics 2003;21:43-50
  11. Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RA, McNeil JJ, et al. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2003;34:2502-7
  12. Lundström E, Smits A, Borg J, Terént A. Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event. Stroke 2010;41:319-24
  13. Moon L. Stroke t